Vanda Pharmaceuticals stock is heading higher on Wednesday as investors in VNDA learn of an acquisition offer for their ...
VNDA) (ā€œVandaā€ or the ā€œCompanyā€) holding over 200,000 shares of the Companyā€™s common stock, announced today that they have delivered a letter to independent members of the Board of Directors of ...
Future Pak submitted 3 proposals since February to acquire all shares of Vanda (VNDA), confirmed most recent cash ...
Shares of Vanda Pharmaceuticals Inc. (VNDA) were gaining more than 36 percent in pre-market activity on the Nasdaq on Wednesday after ...
On Vanda's (VNDA) first-quarter 2024 earnings call, investors' focus is likely to be on the sales performance of its marketed ...
Vanda Pharmaceuticals Inc (NASDAQ:VNDA) concluded the trading at $4.28 Wednesday, April 10, with a fall of -1.83% from its closing price on previous day.
The US Supreme Court has reportedly declined to hear Vanda Pharmaceuticals' (VNDA) case regarding the invalidation of certain ...
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the Supreme Court denied Vanda's petition for a writ of certiorari in its HETLIOZ® Abbreviated New Drug Application litigation ...
The Rights Plan, expiring on April 16, 2025, intends to protect the rights of all current and future stockholders by blocking any entity, person or group from acquiring Vanda without paying an ...
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) confirmed that, since March 2024, it had received several unsolicited proposals from ...